Patents by Inventor Charles U. Smith

Charles U. Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210212611
    Abstract: An oximeter can include a sensor and a processor. The processor can access signal information corresponding to a test signal. The signal information can correspond to a characteristic. The characteristic can be determined using at least one of an AC component and a DC component. The processor can compare the characteristic and a reference value. The processor can adjust the signal, based on the comparison, to set a relationship between the characteristic and the reference value.
    Type: Application
    Filed: May 31, 2019
    Publication date: July 15, 2021
    Inventors: Gregory J. Rausch, Matthew Prior, Charles U. Smith
  • Patent number: 9717447
    Abstract: A device includes a first sensor coupler that is configured to receive a first input signal from a first sensor. The first input signal corresponds to a first physiological parameter and is based on optical excitation of a tissue. The device includes a processor coupled to the first sensor coupler. The processor is configured to generate an output signal based on the first input signal. The first physiological parameter is encoded in the output signal. The output signal differs from the first input signal. The device includes an output coupler configured to communicate the output signal to a remote device.
    Type: Grant
    Filed: June 12, 2014
    Date of Patent: August 1, 2017
    Assignee: Nonin Medical, Inc.
    Inventors: Christopher Larsen, Timothy L. Johnson, Scott Everett Blomberg, Charles U. Smith, Jayant Parthasarathy
  • Publication number: 20140357970
    Abstract: A device includes a first sensor coupler that is configured to receive a first input signal from a first sensor. The first input signal corresponds to a first physiological parameter and is based on optical excitation of a tissue. The device includes a processor coupled to the first sensor coupler. The processor is configured to generate an output signal based on the first input signal. The first physiological parameter is encoded in the output signal. The output signal differs from the first input signal. The device includes an output coupler configured to communicate the output signal to a remote device.
    Type: Application
    Filed: June 12, 2014
    Publication date: December 4, 2014
    Inventors: Christopher Larsen, Timothy L. Johnson, Scott Everett Blomberg, Charles U. Smith, Jayant Parthasarathy
  • Patent number: 8792950
    Abstract: A device includes a first sensor coupler that is configured to receive a first input signal from a first sensor. The first input signal corresponds to a first physiological parameter and is based on optical excitation of a tissue. The device includes a processor coupled to the first sensor coupler. The processor is configured to generate an output signal based on the first input signal. The first physiological parameter is encoded in the output signal. The output signal differs from the first input signal. The device includes an output coupler configured to communicate the output signal to a remote device.
    Type: Grant
    Filed: June 4, 2010
    Date of Patent: July 29, 2014
    Assignee: Nonin Medical, Inc.
    Inventors: Christopher Larsen, Timothy L. Johnson, Scott Everett Blomberg, Charles U. Smith, Jayant Parthasarathy
  • Publication number: 20100312079
    Abstract: A device includes a first sensor coupler that is configured to receive a first input signal from a first sensor. The first input signal corresponds to a first physiological parameter and is based on optical excitation of a tissue. The device includes a processor coupled to the first sensor coupler. The processor is configured to generate an output signal based on the first input signal. The first physiological parameter is encoded in the output signal. The output signal differs from the first input signal. The device includes an output coupler configured to communicate the output signal to a remote device.
    Type: Application
    Filed: June 4, 2010
    Publication date: December 9, 2010
    Applicant: Nonin Medical, Inc.
    Inventors: Christopher Larsen, Timothy L. Johnson, Scott Everett Blomberg, Charles U. Smith, Jayant Parthasarathy
  • Patent number: 5957956
    Abstract: A capacitor-discharge implantable cardioverter defibrillator (ICD) has a relatively smaller mass of less than about 120 grams. The smaller mass of the ICD is achieved by selecting and arranging the internal components of the ICD to deliver a maximum defibrillation countershock optimized in terms of a minimum physiologically effective current (I.sub.pe), rather than a minimum defibrillation threshold energy (DFT). As a result of the optimization in terms of a minimum effective current I.sub.pe, there is a significant decrease in the maximum electrical charge energy (E.sub.c) that must be stored by the capacitor of the ICD to less than about 30 Joules, even though a higher safety margin is provided for by the device. Due to this decrease in the maximum E.sub.
    Type: Grant
    Filed: November 3, 1997
    Date of Patent: September 28, 1999
    Assignee: Angeion Corp
    Inventors: Mark W. Kroll, Theodore P. Adams, Kenneth M. Anderson, Charles U. Smith
  • Patent number: 5827326
    Abstract: A capacitor-discharge implantable cardioverter defibrillator (ICD) has a relatively smaller energy storage capacity of less than about 1.0 Amp-hours. The smaller energy storage capacity of the ICD is achieved by selecting and arranging the internal components of the ICD to deliver a maximum defibrillation countershock optimized in terms of a minimum physiologically effective current (I.sub.pe) rather than a minimum defibrillation threshold energy (DFT). As a result of the optimization in terms of a minimum effective current I.sub.pe, there is a significant decrease in the maximum electrical charge energy (E.sub.c) that must be stored by the capacitor of the ICD to less than about 30 Joules, even though a higher safety margin is provided for by the device. Due to this decrease in the maximum E.sub.
    Type: Grant
    Filed: March 29, 1995
    Date of Patent: October 27, 1998
    Assignee: Angeion Corporation
    Inventors: Mark W. Kroll, Theodore P. Adams, Kenneth M. Anderson, Charles U. Smith
  • Patent number: 5697953
    Abstract: A capacitor-discharge implantable cardioverter defibrillator (ICD) has a relatively longer device life of greater that 5 years. The longer life of the ICD is achieved by selecting and arranging the internal components of the ICD to deliver a maximum defibrillation countershock optimized in terms of a minimum physiologically effective current (I.sub.pe), rather than a minimum defibrillation threshold energy (DFT). As a result of the optimization in terms of a minimum effective current I.sub.pe, there is a significant decrease in the maximum electrical charge energy (E.sub.c) that must be stored by the capacitor of the ICD to less than about 30 Joules, even though a higher safety margin is provided for by the device. Due to this decrease in the maximum E.sub.
    Type: Grant
    Filed: January 11, 1996
    Date of Patent: December 16, 1997
    Assignee: Angeion Corporation
    Inventors: Mark W. Kroll, Theodore P. Adams, Kenneth M. Anderson, Charles U. Smith
  • Patent number: 5645573
    Abstract: The model that is developed in the present invention is based upon the pioneering neurophysiological models of Lapicque and Weiss. The present model determines mathematically the optimum pulse duration, d.sub.p, for a truncated capacitor-discharge waveform employed for defibrillation. The model comprehends the system time constant, RC, where R is tissue resistance and C is the value of the capacitor being discharged, and also the chronaxie time, d.sub.c, defined by Lapicque, which is a characteristic time associated with the heart. The present model and analysis find the optimum pulse duration to be d.sub.p =(0.58)(RC+d.sub.c). Taking the best estimate of the chronaxie value from the literature to be 2.7 ms, permits one to rewrite the optimum pulse duration as d.sub.p =(0.58)RC+1.6 ms.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 8, 1997
    Assignee: Angeion Corporation
    Inventors: Mark W. Kroll, Charles U. Smith
  • Patent number: 5549643
    Abstract: The model that is developed in the invention is based upon the pioneering neurophysiological models of Lapicque and Weiss. The present model determines mathematically the optimum pulse duration, d.sub.p, for a truncated capacitor-discharge waveform employed for defibrillation. The model comprehends the system time constant, RC, where R is tissue resistance and C is the value of the capacitor being discharged, and also the chronaxie time, d.sub.c, defined by Lapicque, which is a characteristic time associated with the heart. The present model and analysis find the optimum pulse duration to be d.sub.p =(0.58)(RC+d.sub.c). Taking the best estimate of the chronaxie value from the literature to be 2.7 ms, permits one to rewrite the optimum pulse duration as d.sub.p =(0.58)RC+1.6 ms. The apparatus makes use of the mathematical definition of optimum pulse duration by storing in the control circuitry of the defibrillation system the actual measured value of the particular capacitor incorporated in the system.
    Type: Grant
    Filed: October 12, 1994
    Date of Patent: August 27, 1996
    Assignee: Angeion Corporation
    Inventors: Mark W. Kroll, Charles U. Smith
  • Patent number: 5431686
    Abstract: The model that is developed in the present invention is based upon the pioneering neurophysiological models of Lapicque and Weiss. The present model determines mathematically the optimum pulse duration, d.sub.p, for a truncated capacitor-discharge waveform employed for defibrillation. The model comprehends the system time constant, RC, where R is tissue resistance and C is the value of the capacitor being discharged, and also the chronaxie time, d.sub.c, defined by Lapicque, which is a characteristic time associated with the heart. The present model and analysis find the optimum pulse duration to be d.sub.p =(0.58)(RC+d.sub.c). Taking the best estimate of the chronaxie value from the literature to be 2.7 ms, permits one to rewrite the optimum pulse duration as d.sub.p =(0.58)RC+1.6 ms.
    Type: Grant
    Filed: February 18, 1992
    Date of Patent: July 11, 1995
    Assignee: Angeion Corporation
    Inventors: Mark W. Kroll, Charles U. Smith
  • Patent number: 5405363
    Abstract: A capacitor-discharge implantable cardioverter defibrillator (ICD) has a relatively smaller displacement volume of less than about 90 cc. The smaller volume of the ICD is achieved by selecting and arranging the internal components of the ICD to deliver a maximum defibrillation countershock optimized in terms of a minimum physiologically effective current (I.sub.pe), rather than a minimum defibrillation threshold energy (DFT). As a result of the optimization in terms of a minimum effective current I.sub.pe, there is a significant decrease in the maximum electrical charge energy (E.sub.c) that must be stored by the capacitor of the ICD to less than about 30 Joules, even though a higher safety margin is provided for by the device. Due to this decrease in the maximum E.sub.
    Type: Grant
    Filed: June 21, 1994
    Date of Patent: April 11, 1995
    Assignee: Angelon Corporation
    Inventors: Mark W. Kroll, Theodore P. Adams, Kenneth M. Anderson, Charles U. Smith